Fundz

Instil Bio, Inc. reported raising $15 Million in an initial SEC Form D filing, from an offering of $15 Million

PUBLIC · TILSep 30, 2019

Amount Raised

$15 Million

$15 Million sold, per SEC Form D (first sale Sep 30, 2019)

Round Type

Venture

DallasBiotechnology

Quick answer

Instil Bio raised $15 Million in a funding round, dated September 30, 2019. Instil Bio is based in Dallas, Texas, United States.

How much did Instil Bio raise?
Instil Bio raised $15 Million in a funding round on September 30, 2019.
What does Instil Bio do?
Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies.
Where is Instil Bio based and how big is it?
Instil Bio is based in Dallas, Texas, United States. Fundz records about 14 employees.
Who are the decision-makers at Instil Bio?
Fundz holds 1 contact at Instil Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Instil Bio that raised within 45 days of this round, from Fundz verified event records.

  • Vyriad raised $24M on November 14, 2019.
  • Luminary Therapeutics raised $5.2M on November 14, 2019.
  • Cupron raised $1.8M (Seed) on November 14, 2019.
  • eGenesis raised $100M on November 14, 2019.
  • ISOThrive raised $4M on November 14, 2019.
  • Lexaria Bioscience raised $180K on November 13, 2019.

Who to call at Instil Bio, and when

A new round usually means Instil Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Instil Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Instil Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Instil Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Instil Bio

Location

3963 Maple Avenue, Suite 350

Dallas, Texas, United States

About

Instil Bio is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. Instil’s lead asset, AXN-2510, is a novel and differentiated PD-L1xVEGF bispecific antibody in development for the treatment of multiple solid tumor cancers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Instil Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts26 people are listed at Instil Bio. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Instil Bio's next move

See what Strategic adds

Instil Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.